Asia Pacific Cancer Therapeutics Market Outlook (2021-2031)
The Asia Pacific Cancer Therapeutics Market size was valued at US$ 36,572.60 Mn in 2024 and is projected to reach US$ 96,537.58 Mn by 2031, growing at a CAGR of 14.97% during 2025 - 2031.
Report Coverage
- Therapy Type: Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, Other Therapy Types
- Indications: Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver & Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channel
US$ 36,572.60 Mn
Market size in 2024
US$ 96,537.58 Mn
Market Size by 2031
14.97%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Cancer Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Cancer Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Cancer Therapeutics Market Regional Analysis
6.2 Asia Pacific Cancer Therapeutics Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Cancer Therapeutics Market Forecast Analysis
7. Asia Pacific Cancer Therapeutics Market Analysis – by Therapy Type
7.1 Chemotherapy
- 7.1.1 Overview
- 7.1.2 Chemotherapy: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Targeted Therapy
- 7.2.1 Overview
- 7.2.2 Targeted Therapy: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Radiation Therapy
- 7.3.1 Overview
- 7.3.2 Radiation Therapy: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Hormone Therapy
- 7.4.1 Overview
- 7.4.2 Hormone Therapy: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Other Therapy Types
- 7.5.1 Overview
- 7.5.2 Other Therapy Types: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Asia Pacific Cancer Therapeutics Market Analysis – by Indications
8.1 Blood Cancer
- 8.1.1 Overview
- 8.1.2 Blood Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Lung Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectal Cancer
- 8.4.1 Overview
- 8.4.2 Colorectal Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
- 8.5.1 Overview
- 8.5.2 Prostate Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
- 8.6.1 Overview
- 8.6.2 Stomach Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
- 8.7.1 Overview
- 8.7.2 Cervical Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver & Intrahepatic Bile Duct Cancer
- 8.8.1 Overview
- 8.8.2 Liver & Intrahepatic Bile Duct Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
- 8.9.1 Overview
- 8.9.2 Thyroid Cancer: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
- 8.10.1 Overview
- 8.10.2 Other Indications: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Asia Pacific Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Channel
- 9.3.1 Overview
- 9.3.2 Online Channel: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Asia Pacific Cancer Therapeutics Market – Asia Pacific Analysis
10.1 Overview
10.2 Asia Pacific- 10.2.1 Asia Pacific Cancer Therapeutics Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 Asia Pacific Cancer Therapeutics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.1.2 China: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.1.3 China: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.2 South Korea: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 South Korea: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.2.2 South Korea: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.2.3 South Korea: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.3 India: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 India: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.3.2 India: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.3.3 India: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.4 Indonesia: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Indonesia: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.4.2 Indonesia: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.4.3 Indonesia: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.5 Australia: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Australia: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.5.2 Australia: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.5.3 Australia: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.6 Malaysia: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Malaysia: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.6.2 Malaysia: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.6.3 Malaysia: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.7 Rest of Asia Pacific: Asia Pacific Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.7.1 Rest of Asia Pacific: Asia Pacific Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.7.2 Rest of Asia Pacific: Asia Pacific Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.7.3 Rest of Asia Pacific: Asia Pacific Cancer Therapeutics Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Astellas Pharma Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Eli Lilly and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Novartis AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck KGaA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 AstraZeneca
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Pfizer Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hoffmann-La Roche Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Johnson & Johnson
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 AbbVie Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Bristol-Myers Squibb Co
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
